BIO - מזומני החברה bio-rad.com

Bio-Rad Laboratories (BIO) maintains stable income through a balance between clinical diagnostics and scientific research. A "razor-and-blade" model featuring high-margin reagents ensures customer loyalty. The volume of highly liquid cash clearly confirms financial stability, where the 1.35 mark records this indicator. The company is currently optimizing capital and developing R&D to scale its diagnostic portfolio.
פילוחים אנליטיים של חברת Bio-Rad Laboratories, Inc. (BIO)

Investors assess the financial autonomy of a business by analyzing liquid assets, which ensure stability during periods of external financing shortages. This indicator aggregates cash and cash equivalents, and given the minimal M&A activity of Bio-Rad Laboratories (BIO) and its focus on organic growth, the company's cash volume serves as a gauge for capital management efficiency without the excessive accumulation of non-working assets.